Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy.

Abstract

OBJECTIVE Because the secretion of dehydroepiandrosterone (DHEA), the exclusive source of sex steroids in postmenopausal women, is already decreased by 60% and continues to decline at the time of menopause, the objective of this study was to examine the effect of intravaginal DHEA on the symptoms and signs of vaginal atrophy. METHODS This prospective… (More)
DOI: 10.1097/gme.0b013e31819e8e2d

Topics

16 Figures and Tables

Cite this paper

@article{Labrie2009IntravaginalD, title={Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy.}, author={Fernand Labrie and David F. Archer and C{\'e}line Bouchard and Michel Fortier and Leonello Cusan and J. Gomez and Ginette Girard and Mira G. Baron and Normand J Ayotte and Michele A Moreau and Robert Dub{\'e} and Isabelle M. C{\^o}t{\'e} and Claude Labrie and Lyne Lavoie and Louise Berger and Lucy Gilbert and C{\'e}line Martel and John P Balser}, journal={Menopause}, year={2009}, volume={16 5}, pages={907-22} }